全文获取类型
收费全文 | 42631篇 |
免费 | 4591篇 |
国内免费 | 139篇 |
专业分类
耳鼻咽喉 | 498篇 |
儿科学 | 1656篇 |
妇产科学 | 1161篇 |
基础医学 | 6122篇 |
口腔科学 | 953篇 |
临床医学 | 5786篇 |
内科学 | 8796篇 |
皮肤病学 | 776篇 |
神经病学 | 3578篇 |
特种医学 | 1197篇 |
外国民族医学 | 4篇 |
外科学 | 4995篇 |
综合类 | 684篇 |
一般理论 | 23篇 |
预防医学 | 4399篇 |
眼科学 | 683篇 |
药学 | 2968篇 |
中国医学 | 106篇 |
肿瘤学 | 2976篇 |
出版年
2023年 | 301篇 |
2022年 | 490篇 |
2021年 | 1029篇 |
2020年 | 754篇 |
2019年 | 1132篇 |
2018年 | 1306篇 |
2017年 | 1009篇 |
2016年 | 1081篇 |
2015年 | 1134篇 |
2014年 | 1487篇 |
2013年 | 2034篇 |
2012年 | 2723篇 |
2011年 | 2673篇 |
2010年 | 1598篇 |
2009年 | 1388篇 |
2008年 | 2283篇 |
2007年 | 2331篇 |
2006年 | 2195篇 |
2005年 | 2099篇 |
2004年 | 1942篇 |
2003年 | 1789篇 |
2002年 | 1633篇 |
2001年 | 859篇 |
2000年 | 791篇 |
1999年 | 804篇 |
1998年 | 457篇 |
1997年 | 409篇 |
1996年 | 355篇 |
1995年 | 335篇 |
1994年 | 305篇 |
1993年 | 251篇 |
1992年 | 540篇 |
1991年 | 525篇 |
1990年 | 488篇 |
1989年 | 449篇 |
1988年 | 441篇 |
1987年 | 403篇 |
1986年 | 419篇 |
1985年 | 413篇 |
1984年 | 331篇 |
1983年 | 306篇 |
1982年 | 244篇 |
1981年 | 246篇 |
1979年 | 284篇 |
1978年 | 244篇 |
1977年 | 222篇 |
1976年 | 204篇 |
1975年 | 197篇 |
1974年 | 231篇 |
1973年 | 237篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
Rebecca Wright Caleb Ferguson Mustafa Bodrick Hanan Balkhy Debra Jackson Patricia M. Davidson 《Journal of clinical nursing》2020,29(13-14):2723-2729
12.
13.
14.
Fiene Marie Kuijper Uma V. Mahajan Seul Ku Daniel A.N. Barbosa Sheila M. Alessi Sherman C. Stein Kyle M. Kampman Brandon S. Bentzley Casey H. Halpern 《Neuromodulation》2022,25(2):253-262
ObjectivesCocaine is the second most frequently used illicit drug worldwide (after cannabis), and cocaine use disorder (CUD)-related deaths increased globally by 80% from 1990 to 2013. There is yet to be a regulatory-approved treatment. Emerging preclinical evidence indicates that deep brain stimulation (DBS) of the nucleus accumbens may be a therapeutic option. Prior to expanding the costly investigation of DBS for treatment of CUD, it is important to ensure societal cost-effectiveness.AimsWe conducted a threshold and cost-effectiveness analysis to determine the success rate at which DBS would be equivalent to contingency management (CM), recently identified as the most efficacious therapy for treatments of CUDs.Materials and MethodsQuality of life, efficacy, and safety parameters for CM were obtained from previous literature. Costs were calculated from a societal perspective. Our model predicted the utility benefit based on quality-adjusted life-years (QALYs) and incremental-cost-effectiveness ratio resulting from two treatments on a one-, two-, and five-year timeline.ResultsOn a one-year timeline, DBS would need to impart a success rate (ie, cocaine free) of 70% for it to yield the same utility benefit (0.492 QALYs per year) as CM. At no success rate would DBS be more cost-effective (incremental-cost-effectiveness ratio <$50,000) than CM during the first year. Nevertheless, as DBS costs are front loaded, DBS would need to achieve success rates of 74% and 51% for its cost-effectiveness to exceed that of CM over a two- and five-year period, respectively.ConclusionsWe find DBS would not be cost-effective in the short term (one year) but may be cost-effective in longer timelines. Since DBS holds promise to potentially be a cost-effective treatment for CUDs, future randomized controlled trials should be performed to assess its efficacy. 相似文献
15.
16.
Marie Warrer Petersen Tine Sylvest Meyhoff Marie Helleberg Maj-Brit Nørregaard Kjær Anders Granholm Carl Johan Steensen Hjortsø Thomas Steen Jensen Morten Hylander Møller Peter Buhl Hjortrup Mik Wetterslev Gitte Kingo Vesterlund Lene Russell Vibeke Lind Jørgensen Klaus Tjelle Thomas Benfield Charlotte Suppli Ulrik Anne Sofie Andreasen Thomas Mohr Morten H. Bestle Lone Musaeus Poulsen Mette Friberg Hitz Thomas Hildebrandt Lene Surland Knudsen Anders Møller Christoffer Grant Sølling Anne Craveiro Brøchner Bodil Steen Rasmussen Henrik Nielsen Steffen Christensen Thomas Strøm Maria Cronhjort Rebecka Rubenson Wahlin Stephan Jakob Luca Cioccari Balasubramanian Venkatesh Naomi Hammond Vivekanand Jha Sheila Nainan Myatra Christian Gluud Theis Lange Anders Perner 《Acta anaesthesiologica Scandinavica》2020,64(9):1365-1375
Introduction
Severe acute respiratory syndrome coronavirus-2 has caused a pandemic of coronavirus disease (COVID-19) with many patients developing hypoxic respiratory failure. Corticosteroids reduce the time on mechanical ventilation, length of stay in the intensive care unit and potentially also mortality in similar patient populations. However, corticosteroids have undesirable effects, including longer time to viral clearance. Clinical equipoise on the use of corticosteroids for COVID-19 exists.Methods
The COVID STEROID trial is an international, randomised, stratified, blinded clinical trial. We will allocate 1000 adult patients with COVID-19 receiving ≥10 L/min of oxygen or on mechanical ventilation to intravenous hydrocortisone 200 mg daily vs placebo (0.9% saline) for 7 days. The primary outcome is days alive without life support (ie mechanical ventilation, circulatory support, and renal replacement therapy) at day 28. Secondary outcomes are serious adverse reactions at day 14; days alive without life support at day 90; days alive and out of hospital at day 90; all-cause mortality at day 28, day 90, and 1 year; and health-related quality of life at 1 year. We will conduct the statistical analyses according to this protocol, including interim analyses for every 250 patients followed for 28 days. The primary outcome will be compared using the Kryger Jensen and Lange test in the intention to treat population and reported as differences in means and medians with 95% confidence intervals.Discussion
The COVID STEROID trial will provide important evidence to guide the use of corticosteroids in COVID-19 and severe hypoxia.17.
Renaud Snanoudj Nassim Kamar Elisabeth Cassuto Sophie Caillard Marie Metzger Pierre Merville Antoine Thierry Isabelle Jollet Philippe Grimbert Dany Anglicheau Marc Hazzan Gabriel Choukroun Bruno Hurault De Ligny Bénedicte Janbon Vincent Vuiblet Anne Devys Yann Le Meur Michel Delahousse Jean-Luc Taupin 《Kidney international》2019,95(6):1471-1485
18.
19.
20.
This is the third and final part of a series of articles that report the findings of a study that investigated the effects of a summer externship program on the transition into a professional role among nurses who participated in a summer nurse externship program at an acute care pediatric hospital. Specifically, this article reports the retention and recruitment benefits of a summer nurse externship program for the institution from 1998 through 2003. A total of 153 externs out of the 193 (79.0%) assumed a registered nurse position at the institution, and 77% remained in that role for 12 months. Overall, the nurse extern program for this institution appeared to be an effective recruitment and retention strategy that is on par with the institution and national data for retention and turnover data. 相似文献